Stay updated on Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the efficacy or safety data related to the novel combination of pembrolizumab plus induction GM-CSF in patients with advanced biliary cancers at the University of California, San Francisco.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:48.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.' This change provides a more detailed explanation of the eligibility criteria for participation in the study.
    Difference
    52%
    Check dated 2024-05-22T21:35:06.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:56:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.